troke is the second leading cause of death and third leading cause of disability worldwide.
Stroke

February 2016
Because CO can rapidly equilibrate across the alveolar-capillary barrier, endogenous CO levels can be approximated by measuring exhaled CO concentrations. 18 Paredi et al 19 demonstrated that higher exhaled CO concentrations were correlated positively with the presence of diabetes mellitus, and that CO levels were directly related to blood glucose concentrations. In the Framingham Heart Study (FHS), we have previously reported that exhaled CO levels are positively associated with prevalent and incident metabolic syndrome, prevalent subclinical cardiovascular disease (CVD), and incident CVD. 20, 21 Furthermore, subclinical CVD was associated with incident CVD in the setting of high but not low CO, suggesting that CO may be a biological modulator of the progression from subclinical to manifest CVD. 21 Accordingly, we hypothesized that exhaled CO is associated with the presence of subclinical cerebrovascular disease on magnetic resonance imaging (MRI) cross-sectionally and with the incidence of stroke/ transient ischemic attack (TIA) prospectively. We tested these hypotheses in the large, community-based FHS.
Methods
Study Sample
Enrollment and design of the Framingham Offspring Study have been described previously. 22 For the present investigation, 3532 participants attending the sixth examination cycle (1995-1998) were considered eligible for analysis, and 2 study samples were constructed. For both samples, participants were excluded for prevalent stroke/ TIA (n=87), serum creatinine ≥2 mg/dL (n=14), missing CO measurements (n=71), unknown smoking status (n=3), and missing covariates (n=44), yielding a baseline study sample of 3313 individuals. To analyze cross-sectional associations of exhaled CO with MRI traits, participants were additionally excluded for refusing MRI or unavailable MRI measures (n=1269, Table I in the online-only Data Supplement), prevalent dementia or other neurologic disease (n=45), and interim stroke/TIA between the sixth examination cycle and MRI (n=17), yielding a second final study sample of 1982 individuals for these analyses. For assessing the prospective associations of exhaled CO and incident stroke/TIA, the baseline sample (n=3313) was used. Medical history, anthropometry, a cardiovascular-targeted physical examination, electrocardiography, and phlebotomy were performed for all attendees of the sixth examination cycle at the FHS clinic. All study protocols were approved by the Boston University Medical Center Institutional Review Board, and all participants provided written informed consent.
Measuring Exhaled Carbon Monoxide
Exhaled CO was measured at rest using the Ecolyzer (2000 series) instrument (Energetics Science Inc., Elmsford, NY) during the third through sixth examination cycles as described previously. 20 This method has been shown to be reproducible and to accurately reflect blood concentrations of CO. 23 At each examination, the average of 2 measurements was recorded. Exhaled CO levels >50 parts per million (p.p.m.; n=4) were censored and considered equivalent to 50 p.p.m. to reduce excess leverage by extreme outliers. For the present analyses, the available CO measurements from examination cycles 3 through 6 were averaged for each participant.
23
Brain MRI Outcomes
Details of brain MRI image acquisition, analysis, and interrater reliability have been previously reported. 24 Briefly, brain MRIs were performed (1999-2005) on 2230 Framingham Offspring participants who attended the seventh examination cycle. Images were acquired on a Siemens 1T or 1.5T scanner, with 3-dimensional T1-and T2-weighted double spin-echo images acquired in 4 mm contiguous slices (repetition time was 2420 milliseconds; echo time 1 = 20 milliseconds/echo time 2 = 90 milliseconds; echo train of 8 milliseconds, field of view 22 cm; matrix 182 × 256 interpolated to 256 × 256 with 1 excitation). The white-matter hyperintensity volume (WMHV) and total cerebral brain parenchymal volume (total cerebral brain volume, TCBV) were measured by automated procedure, 25 and each was divided by total cranial volume to control for head size. Prevalent silent cerebral infarcts (SCIs) >3 mm were identified manually. The images were analyzed by operators blinded to the participants' clinical characteristics, exposures, and outcomes.
Outcome Events
The FHS protocol for stroke surveillance and adjudication have been reported elsewhere. 26 Briefly, participants in the FHS are under active surveillance for stroke/TIA. An acute onset neurologic deficit of presumed or definite vascular pathogenesis is described as stroke if lasting for >24 hours and TIA if symptoms last ≤24 hours. Clinical features, imaging studies, and information from post-mortem examinations are used when available. These events have been adjudicated by a committee of at least 2 neurologists at a consensus review.
Covariates
Blood pressure, body mass index, plasma total and high-density lipoprotein cholesterol, fasting blood glucose, B-type natriuretic peptide (BNP), and C-reactive protein (CRP) were measured at the FHS clinic during the sixth examination cycle. Diabetes mellitus was defined as fasting blood glucose ≥126 mg/dL or receiving treatment for diabetes mellitus. Self-reported smoking status and hypertension treatment status were ascertained by questionnaire. FHS participants are under continuous surveillance for CVD and atrial fibrillation, which are adjudicated by a committee of 3 physicians based on review of clinic and hospital records.
Statistical Analysis
Exhaled CO was the exposure of interest for all analyses. Each participant was placed into one of the 3 groups (creating whole number approximate tertiles) according to average CO concentration ≤4 p.p.m., >4 and ≤5 p.p.m., and >5 p.p.m., as detailed previously. 21 In primary analyses, the CO categories were analyzed separately with the lowest tertile serving as the referent. In secondary analyses, 2 categories were grouped together and CO was analyzed as a dichotomous variable. The analyses were performed in the whole sample, and repeated in nonsmokers only.
To evaluate the associations of exhaled CO with brain MRI traits, we used multivariable linear (for WMHV and TCBV) and logistic (for SCI) regression models. WMHV was natural logarithmically transformed (because of its skewed distribution) and analyzed according to age-specific z scores. Model 1 was adjusted for sex and age 2 , because of a previously demonstrated quadratic relation between age and several of the MRI measures. 27 Model 2 was adjusted additionally for systolic blood pressure, hypertension treatment status, diabetes mellitus, total/high-density lipoprotein cholesterol, body mass index, smoking status, prevalent atrial fibrillation, prevalent CVD, and the time interval between examination cycle 6 and the MRI measurements.
For evaluation of the prospective associations of exhaled CO and stroke/TIA, we used Cox proportional hazards regression models after confirming that the proportionality of hazards assumption was met. Model 1 was adjusted for age and sex. Model 2 was additionally adjusted for systolic blood pressure, hypertension treatment status, diabetes mellitus, total/high-density lipoprotein cholesterol, body mass index, smoking status, prevalent atrial fibrillation, and prevalent CVD. Model 3 was adjusted additionally for the cardiovascular biomarkers of BNP and CRP, which were log transformed. Penalized splines were constructed to examine for nonlinearity. In secondary analyses, we evaluated the associations of exhaled CO with stroke only.
In both the cross-sectional and the prospective analyses, we examined for evidence of the effect modification by systolic blood pressure and antihypertensive treatment status. A 2-tailed P value of by guest on November 18, 2017 http://stroke.ahajournals.org/ Downloaded from <0.05 was used to assess statistical significance. Analyses were performed using SAS Software version 9.3 (Cary, NC).
Results
Characteristics of the 2 samples are shown in Table 1 and  Table II in the online-only Data Supplement. Our total study sample consisted of middle-aged to older individuals, and over half were women.
Association of Exhaled CO With Subclinical Vascular Brain Injury
Cross-sectional associations of exhaled CO and MRI measures of subclinical cerebrovascular disease are shown in Table 2 . Compared with the low CO tertile (≤4 p.p.m.), individuals with the highest CO (>5 p.p.m.) had increased WMHV in both minimally adjusted and multivariable-adjusted models. These results were consistent in the whole sample and in nonsmokers. Minimal attenuation of the effect estimates was observed upon multivariable adjustments (~13% reduction in the β-coefficients).
Prevalence of SCIs was also marginally associated with exhaled CO. The highest CO tertile was associated with a 46% increase in the odds of having a SCI compared with the lowest CO tertile in minimally adjusted models for the whole sample (P=0.04). Multivariable adjustment attenuated this association. No statistically significant associations were observed in the nonsmokers.
Lower TCBV was observed for the highest CO tertile after adjusting for age and sex, in the whole sample and in nonsmokers. In the intermediate exhaled CO group, however, we observed a statistically significant association in the opposite direction (ie, an increased TCBV) in multivariable-adjusted models.
In secondary analyses, CO was modeled as a dichotomous variable (with categories of CO ≤4 versus CO >4 and CO ≤5 versus CO >5) and similar findings were observed (Table III in the online-only Data Supplement). Effect modification by systolic blood pressure and antihypertensive treatment status was investigated using multiplicative interaction terms that were not statistically significant.
Exhaled CO and Incident Stroke/TIA
A total of 3313 individuals (53% women) were followed for a mean of 12.9 years. Incident stroke/TIA developed in 231 participants (7.0%; 52% of whom were women). In age-and sex-adjusted models, the intermediate and highest tertiles of exhaled CO had 67% and 97% higher incidence of stroke/TIA when compared with the lowest CO tertile, respectively (P for both <0.01), Table 3 and the Figure. These associations were also statistically significant in nonsmokers. The hazard ratios demonstrated some attenuation upon multivariable adjustment for known stroke risk factors, but no additional attenuation was observed when additional adjustments were made for the circulating biomarkers BNP and CRP.
In secondary analyses, CO was modeled as a dichotomous variable (CO ≤4 versus CO >4) and similar associations were observed (Figure and Table IV in the online-only Data Supplement). Effect modification by systolic blood pressure and antihypertensive status was not observed (data not shown). We also evaluated the associations of exhaled CO tertiles with stroke only (after removing TIA events from the outcome) and the findings were similar (data not shown).
Discussion
In the present investigation of mostly middle-aged individuals in the community, exhaled CO concentrations were associated with MRI measures of subclinical cerebrovascular disease cross-sectionally and with the incidence of stroke/TIA prospectively. In minimally adjusted models, persons in the highest exhaled CO tertile had lower TCBV, greater burden of WMHV, and were more likely to have prevalent SCI when compared with persons in the lowest CO tertile. These associations were partially attenuated upon adjustment for known stroke risk factors. In prospective analyses, higher exhaled CO was associated with an increased risk of stroke during approximately 13 years of follow-up. The effect estimate was attenuated after adjustment for traditional stroke risk factors but remained robust after adjusting for the circulating biomarkers BNP and CRP. These findings are consistent with those of Cheng et al, 20, 21 which established that exhaled CO is associated with cardiometabolic traits, subclinical CVD, and the incidence of CVD, a composite outcome comprising different types of vascular outcomes. Our findings support a similar role for exhaled CO when stroke/TIA was analyzed as a distinct outcome. Furthermore, the partial attenuation of the effect estimates after adjusting for stroke risk factors supports the hypothesis that CO may be physiologically related to vascular risk factors. The lack of attenuation upon adjustment for BNP and CRP, in contrast, suggests that CO acts independently of myocardial stress (BNP) and inflammation (CRP) to affect stroke risk.
Pathophysiologic Mechanisms Linking Elevated Endogenous CO Concentrations With Stroke/TIA
CO is essential for healthy development and, in physiologic concentrations, serves a number of protective functions. [28] [29] [30] Conversely, elevated CO concentrations may contribute to vascular disease and stroke via several mechanisms. 31 At TCBV and WMHV are expressed as % of intracranial volume. WMHV was log transformed and analyzed according to age-specific z score. Regression coefficient and odds ratios represent changes associated with each CO tertile compared with the lowest CO tertile (referent). Model 1 was adjusted for sex and age 2 . Model 2 was adjusted for sex, age 2 , systolic blood pressure, hypertension treatment, diabetes mellitus, total/HDL cholesterol, body mass index, smoking status, prevalent atrial fibrillation, prevalent cardiovascular disease, interval between exam 6 and MRI. β indicates regression coefficient; CI, confidence interval; CO, carbon monoxide; HDL, high-density lipoprotein; MRI, magnetic resonance imaging; OR, odds ratio; p.p.m., parts per million; SE, standard error; SCI, silent cerebral infarct; TCBV, total cerebral brain volume; and WMHV, white matter hyperintensity volume. HR represents the relative hazard for each CO category compared with the referent. Model 1 was adjusted for age and sex. Model 2 was additionally adjusted for systolic blood pressure, hypertension treatment status, diabetes mellitus, total/HDL cholesterol, body mass index, smoking, prevalent cardiovascular disease, and prevalent atrial fibrillation. Model 3 was additionally adjusted for log-BNP and log-CRP. N=3189 for the whole sample and N=2715 for nonsmokers. BNP indicates B-type natriuretic peptide; CI, confidence interval; CO, carbon monoxide; CRP, C-reactive protein; HDL, high-density lipoprotein; HR, hazard ratio; p.p.m., parts per million; and TIA, transient ischemic attack.
by guest on November 18, 2017 http://stroke.ahajournals.org/ Downloaded from high concentrations, endogenous CO inhibits the production of endothelial NO, thereby reducing the antithrombogenic activity of the endothelial layer and increasing recruitment of inflammatory cells. 13 In fact, CO may directly enhance the migration of inflammatory cells via stimulation of cyclic guanosine monophosphate. 32 Furthermore, endogenous CO may lead to increased blood glucose by stimulating glucagon release.
14 CO seems to be an important modulator of cardiometabolic disease, as evidenced by a rat model of the metabolic syndrome, in which elevated CO was found to promote hypertension and endothelial dysfunction independent of its effects on metabolic variables. 17 Lastly, CO is known to result in oxidative stress and free radical production, which contribute to cardiometabolic disease pathogenesis. 15 In addition to its individual associations with cardiometabolic and vascular pathways, CO concentrations reflect activity of heme oxygenase (HO), which produces CO during heme metabolism. 8 HO-1 is an increasingly recognized modulator of cardiovascular risk, and its expression is inducible by physiologic stressors, such as circulating phospholipids, vascular injury, hypertension, hyperglycemia, smoking, and laminar shear stress. 8, [33] [34] [35] [36] In autopsy samples of human coronary arteries, HO-1 activity was shown to be overexpressed in atherosclerotic plaques and to correlate with the degree of stenosis. 37 HO-1 has also been demonstrated to be an essential driver of insulin resistance. 38 The degree to which elevated endogenous CO concentrations lead to adverse cardiometabolic adaptations independently or primarily via its relations with the activity of HO-1 remains unknown.
Exhaled CO and Stroke Incidence
To our knowledge, this is the first study establishing an association of exhaled CO with stroke incidence. These findings are consistent with previous work by our group demonstrating associations of exhaled CO with cardiometabolic traits, subclinical CVD, and incident CVD. Therefore, our findings might be explained by shared risk factors and pathophysiology of both stroke and coronary heart disease. Although animal models and clinical studies have previously demonstrated associations of elevated endogenous CO with various molecular processes that might mediate the increased stroke risk, the precise mechanisms responsible for the observed associations have not been determined. Furthermore, it remains unknown whether endogenous CO may serve as an essential biological modulator of stroke risk versus a biomarker of physiologic stress and, perhaps, HO-1 activity.
Limitations and Strengths
Several limitations of this study warrant mention. Exhaled CO was measured as an approximation of endogenous CO production. Although gas chromatography remains the reference standard for measuring blood CO concentrations, exhaled CO has been previously determined to be accurate and reproducible for measuring circulating CO. 23 However, CO in the 
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blood is a reflection of both endogenous CO production and exogenous CO exposure from several sources including cigarette smoke and ambient air pollution. Current smoking was ascertained by questionnaire, but misclassification due to misreporting of current smoking, previous smoking history, or inability to control for secondhand smoke exposure is possible. Ambient air pollution is also known to contain CO and to contribute to atherosclerotic vascular disease. 39 Environmental CO exposure may be affected by a number of factors including automobile type, 40 distance from major roadways, 41 and home heating apparatuses, such as kerosene stoves. 42 Secular trends showing decreasing CO concentrations in ambient air in recent decades further complicate this issue. 43 Lastly, we have not evaluated other environmental pollutants, such as nitric oxides or sulfur oxides, in this present investigation. Thus, comprehensive CO exposure histories have not been assessed in our analyses. Environmental or personal sensors might be used to more completely control for exogenous CO exposure and the role of other air pollutants in future epidemiologic studies evaluating stroke risk. In addition, CO measurements and brain MRI scans were noncontemporaneous, with an average interval of 3.7 years between them (even though we adjusted for this interval in multivariable analyses). This time lag between assessment of exposure and outcome could potentially introduce a regression dilution bias, which would likely lead to underestimation of the true effect, or bias us towards the null hypothesis of no association between CO and the outcomes evaluated. Finally, the study sample was composed of mostly middle-aged white individuals of European descent; thus, the generalizability of our findings to other populations remains unknown. As certain ethnic and geographic groups are disproportionally affected by stroke, 44 examining the associations of CO and stroke risk in other populations would be of great interest.
Notwithstanding these limitations, our study has several strengths including use of a rigorously implemented, standardized measure of CO exposure in a large, communitybased population of adults free of clinical stroke at baseline. In addition, the opportunity to analyze time-averaged measures of CO allowed for precise estimates of the exposure variable for each individual. Furthermore, the observations that exhaled CO is related to both incident stroke and subclinical cerebrovascular injury on brain MRI in the whole sample and in nonsmokers alone suggests a true biological effect in our study.
Conclusions
In our large, community-based sample of individuals free of clinical stroke at baseline, higher levels of exhaled CO were associated with MRI measures of subclinical cerebrovascular disease cross-sectionally and with incident stroke/TIA prospectively. These findings are consistent with experimental data linking higher endogenous CO and activation of the HO pathway with vascular dysfunction and cardiometabolic risk. Future investigations are warranted to evaluate whether exhaled CO might be a useful clinical biomarker of future stroke risk in select individuals, and if modulation of the CO or HO pathways might serve to reduce stroke risk.
